Anti-cancer drugs blocking the PD-1 pathway - known as checkpoint inhibitors - are now FDA-approved for melanoma, lung cancer and several other types of cancer. These drugs are often described as "releasing the brakes" on ...
Mar 9, 2017
0
231
Several personality traits related to psychopathy—especially being openly antagonistic—predict a tendency to view others as merely sex objects, finds a study by psychologists at Emory University. The journal Personality ...
Jan 27, 2020
5
42
(Medical Xpress)—A compassion-based meditation program can significantly improve a person's ability to read the facial expressions of others, finds a study published by Social Cognitive and Affective Neuroscience. This ...
Oct 4, 2012
0
0
Science is finally confirming what grandma knew all along: infants wake up taller right after they sleep.
May 1, 2011
1
0
A large proportion of genetically caused deafness in humans may be reversible by compensating for a missing protein, based on discoveries in mice.
Feb 23, 2007
0
0
Research on immune cells "exhausted" by chronic viral infection provides clues on how to refine cancer immunotherapy. The results are scheduled for publication in Immunity.
Dec 3, 2019
0
45
Individuals with fragile X syndrome, the most common inherited form of intellectual disability, often develop epilepsy, but so far the underlying causes are unknown. Researchers have now discovered a potential mechanism that ...
Apr 12, 2011
0
0
Sequencing a patient's entire genome to discover the source of his or her disease is not routine – yet. But geneticists are getting close.
Feb 3, 2012
0
0
(Medical Xpress)—Quick eye movements, called saccades, that enable us to scan a visual scene appear to act as a metronome for pushing information about that scene into memory.
Jul 31, 2013
2
0
Researchers at Emory University have found that depressed patients who have not responded to multiple antidepressants exhibit evidence of increased inflammation. Findings were recently published online in the journal, Psychoneuroendocrinology.
Jun 11, 2018
0
62
